Extended-Spectrum β-Lactamases: Dilemmas in Detection and Therapy

Antimicrobics and Infectious Diseases Newsletter

Volumn 16, Issue 8, 1997, Pages 57-61

  Patterson, Jan E ^a   Rech, Melanie ^a   Jorgensen, James H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041543084     PISSN: 1069417X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1069-417X(00)80027-8     Document Type: Article

References (32)

1. Bingen EH, Desgardins P, Ariel G, Bourgeois F, Mariani-Kurkdjian P, Lambert-Zechovsky NY, Denamur E, Philippon A, Elion J: 1993. Molecular epidemiology of plasmid spread among extended broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 31:179-184.
2. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K: 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563-569.
3. Branger C, Bruneau B, Lesimple AL, Bouvet PJM, Berry P, Sevali-Garcia J, Lambert-Zechovsky N: 1997. Epidemiological typing of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. J Hosp Infect 36:23-36.
4. French GL, Shannon KP, Simmons N: 1996. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam - β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 34:358-363.
5. Garner JS and the Hospital Infection Control Practices Advisory Committee: 1996. Guideline for isolation precautions in hospitals. Am J Infect Control 24:24-52.
6. Gouby A, Neuwirth C, Bourg G, Bouziges N, Carles-Nurit MJ, Despaux E, Ramuz M: 1994. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 32:301-305.
7. Horii T, Arakawa Y, Ohta M, Ichiyama S, Wacharotayankun R, Kato N: 1993. Plasmid-mediated ampC-type β-lactamase isolated from Klebsiella pnumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob Agents Chemother 37:984-990.
8. Jacoby GA: 1997. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin N Amer 11:875-887.
9. Jacoby GA, Bush K: 1997. Amino acid sequences for TEM, SHV and OXA extended-spectrum β-lactamases. http://www.lahey.hitchcock.org/pages/ lhc/studies/webt.htm.
10. Jacoby GA, Han P: 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34:908-911.
11. Jacoby GA, Medeiros AA, O'Brien TF, Pinto ME, Jiang H: 1988. Broad-spectrum, transmissible β-lactamases. N Engl J Med 319:723-724.
12. Jarlier V, Nicolas MH, Fournier G, Philippon A: 1988. Extended broadspectrum β-lactamases confering transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 10:867-878.
13. Jett BD, Ritchie DJ, Reichley R, Bailey TC, Sahm DF: 1995. In vitro activities of various β-lactam antimicrobial agents against clinical isolates of Escherchia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob Agents Chemother 39:1187-1190.
14. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA: 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J Clin Microbiol 32:691-696.
15. Martinez-Martinez L, Hernandes-Alles S, Alberti S, Tomas JM, Benedi VJ, Jacoby GA: 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 40:342-348.
16. Martinez-Martinez L, Pascual A, Jacoby GA: 1998, Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
17. Medeiros AA, Creelin J: 1997. Comparative susceptibility of clinical isolates producing extended-spectrum β-lactamases to ceftibuten: effect of large inocula. Pediatr Infect Dis J 16:S49-55.
18. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ: 1993. Nosocomial outbreak of Klebslella infection resistant to late-generation cephalosporins. Ann Int Med 119:353-358.
19. Monnet DL, Biddle JW, Edwards JR, Culver DH, Tolson JS, Martone WJ, Tenover FC, Gaynes RP, and the National Nosocomial Infections Surveillance System: 1997. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 18:492-498.
20. Naumovski L, Quinn JP, Miyashiro D et al.: 1992. Outbreak of ceftazidime resistance due to a novel extended-specrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 36:1991.
21. Paterson DL, Ko WC, Mohapatra S, Van Gottberg A, Mulazimoglu L, Casellas JM, Klugman KP, Trenholme GM, Wagener MM, Yu VL: Klebsiella pneumoniae bacteremia: impact of extended spectrum β-lactamase production in a global study of 216 patients. (Abstract J210). Presented at the 37th Interscience Congress on Antimicrobial Agents and Chemotherapy, September 28-October 1, 1997, Toronto, Canada.
22. Philippon A, Arlet G, Lagrange PH: 1994. Origin and impact of plasmid-mediated extended-spectrum β-lactamases. Eur J Clin Microbiol Infecl Dis 13(supplement 1): 17-29.
23. Pornull KJ, Rodrigo G, Dornbusch K: 1994. Production of a plasmid-mediated AmpC-like β-lactamase by a Klebsiella pneumoniae septicaemia isolate. J Antimicrob Chemother 34:943-954.
24. Prodinger WM, Fille M, Bauerfeind A, Stemplinger I, Amann S, Pfausler B, Lass-Florl C, Dierich MP: 1996. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 34:564-568.
25. Rice LB, Carias LL, Bonomo RA, Shlaes DM: 1996. Molecular genetics of resistance to both ceftazidime and β-lactam -β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy. J Infect Dis 173:151-158.
26. Rice LB, Eckstein EC, De Vente J, Shlaes DM: 1996. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 223:118-124.
27. Rice LB, Willey SH, Papanicolaou GB, Medeiros AA, Eliopoulos GM, Moellering RC, Jacoby GA: 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chroniccare facility. Antimicrob Agents Chemother 34:2193-2199.
28. Roussel-Delvallez M, Sirot D, Berrouane Y, Goffart M, Gourde B, Wallet F, Courcol RJ: 1995. Bactericidal effect of β-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended-spectrum β-lactamase. J Antimicrob Chemother 36:241-246.
29. Sader HS, Pfaller MA, Jones RN: 1994. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum β-lactamase-producing Enterobacateriaceae. Diagn Microbiol Infect Dis 20:203-208.
30. Sanders CC, Barry AL, Washington JA, Shubert C, Moland ES, Trazewski MM, Knapp C, Mulder: Detection of extended-spectrum β-lactamase-producing members of the family Enterobacteriaceae with the VITEK ESBL test. J Clin Microbiol 34:2997-3001.
31. Schiappa DA, Hayden MJ, Matushek MG, Hashemi FN, Sullivan J, Smith KY, Miyashiro D, Quinn JP, Weinstein RA, Trenholme GM: 1996. Ceftazidime-resistant Klebsiella pneumoniae and Escherchia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174:529-536.
32. Thauvin-Eliopoulos C, Tripodi MF, Moellering Jr. RC, Eliopoulos GM: 1997. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intraabdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 41:1053-1057.